Charming Medical Ltd
MCTA Nasdaq· Services-Misc Health & Allied Services, Nec
KIRA · Stoqly’s AI analyst, in plain words
- Charming Medical Ltd had $4.8M of revenue in fiscal 2026, down 22.7% on the year before.
- Its operating margin was −0.6%, down 22.9 pts: of every 100 in sales, about −1 is left after running the business.
- Charming Medical Ltd lost $0.0M in fiscal 2026.
- Free cash flow was −$1.6M in fiscal 2026, −32.4% of revenue.
- Charming Medical Ltd has $4.3M more cash than debt.
Market cap
—
P/E
—
Revenue
$4.8M
Net income
−$0.0M
Free cash flow
−$1.6M
Operating margin
−0.6%
Charming Medical Ltd in 30 seconds · fiscal 2026
Are sales growing?
−22.7%
No. Sales fell 22.7% last year.
Does it make a profit?
−0.5%
No. It lost money last year.
Does profit turn into cash?
−32.4%
No. It spent more cash than it brought in.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
2 / 9
Weak. It passes 2 of 9 health tests.
What Charming Medical Ltd does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 20-F · Jul 30, 2026
- Legal name
- Charming Medical Ltd
- CIK
- 0002035992
Charming Medical Ltd · MCTA
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $6.0M | $6.2M | $4.8M |
| Revenue growth | — | 3.4% | −22.7% |
| Gross margin | 99.8% | 99.8% | 99.3% |
| Operating margin | 16.8% | 22.3% | −0.6% |
| Net income | $0.8M | $1.2M | −$0.0M |
| Net margin | 12.9% | 19.3% | −0.5% |
| Diluted EPS | $0.05 | $0.08 | $0.00 |
| Cash | |||
| Cash from operations | $0.3M | $0.4M | −$1.2M |
| Capital expenditure | $0.2M | $0.3M | $0.3M |
| Free cash flow | $0.1M | $0.1M | −$1.6M |
| FCF margin | 1.4% | 2.2% | −32.4% |
| Share count change | — | 0.0% | 5.3% |
| Debt and strength | |||
| Cash and short-term investments | $2.1M | $0.8M | $4.7M |
| Debt incl. finance leases | — | $0.4M | $0.4M |
| Shareholders' equity | −$1.1M | $0.0M | $5.2M |
| Net debt / EBITDA | — | −0.2x | −23.2x |
| Current ratio | — | 0.7x | 1.9x |
| Interest coverage | 38.7x | 66.5x | −1.8x |
| Returns and quality | |||
| Return on capital | — | — | −2.2% |
| Return on equity | — | — | −0.9% |
| Return on tangible equity | — | 2,437.2% | −0.4% |
| Piotroski F-score | — | — | 2 |
| Altman Z'' | — | −0.1 | 3.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Charming Medical Ltd · MCTA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0002035992). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.